Case Report Open Access
Copyright ©The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Jul 14, 2018; 24(26): 2915-2920
Published online Jul 14, 2018. doi: 10.3748/wjg.v24.i26.2915
Gastric adenocarcinoma of fundic gland type with signet-ring cell carcinoma component: A case report and review of the literature
Keita Kai, Department of Pathology, Saga University Hospital, Saga 849-8501, Japan
Masaaki Satake, Department of Gastroenterology, Koga Hospital 21, Kurume 839-0801, Japan
Osamu Tokunaga, Department of Pathology, Shin Koga Hospital, Kurume 830-8577, Japan
ORCID number: Keita Kai (0000-0003-1553-2598); Masaaki Satake (0000-0003-2264-8687); Osamu Tokunaga (0000-0002-4976-1148).
Author contributions: Kai K is the main author of this article; Satake M was attending doctor and performed endoscopic submucosal dissection; Kai K and Tokunaga O performed pathological diagnosis; Tokunaga O and Satake M reviewed the manuscript; all authors have read and approved the final manuscript.
Informed consent statement: Written informed consent was obtained.
Conflict-of-interest statement: The authors declare that there are no conflicts of interest.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Keita Kai, MD, PhD, Associate Professor, Department of Pathology, Saga University Hospital, Nabeshima 5-1-1, Saga City, Saga 849-8501, Japan. kaikeit@cc.saga-u.ac.jp
Telephone: +81-952-343264 Fax: +81-952-342055
Received: April 13, 2018
Peer-review started: April 13, 2018
First decision: May 21, 2018
Revised: May 22, 2018
Accepted: June 9, 2018
Article in press: June 9, 2018
Published online: July 14, 2018

Abstract

A depressed lesion was found at a gastric angle of 76-year-old Japanese woman by esophagogastroduodenoscopy. Four years prior, she was diagnosed with a Helicobacter pylori infection but no eradication was performed. The pathological diagnosis of biopsy specimens was signet-ring cell carcinoma. Endoscopic submucosal dissection (ESD) was performed. Histopathological examination of the ESD specimen revealed proliferation of well-differentiated tubular adenocarcinoma mimicking fundic gland cells at the deep layer of the lamina propria mucosae. These tumor cells expressed focally pepsinogen-I, diffusely MUC6, and scattered H+/K+ ATPase according to immunohistochemistry. Therefore, we diagnosed this tumor as gastric adenocarcinoma of fundic gland type (GA-FG). Adjacent to the GA-FG, proliferation of signet-ring cell carcinoma which diffusely expressed MUC 2 and MUC 5AC was observed. Intestinal metaplasia was focally observed in the surrounding mucosa of the signet-ring cell carcinoma. To the best of our knowledge, this is the first case report of GA-FG with a signet-ring cell carcinoma component. The origin of signet-ring cell carcinoma, i.e., whether it accidentally arose from a non-neoplastic mucosa and coexisted with the GA-FG or dedifferentiated from the GA-FG is unclear at present. We expect the accumulation of similar cases and further analysis to clarify this issue.

Key Words: Gastric adenocarcinoma of fundic gland type, Endoscopic submucosal dissection, Helicobacter pylori, Intestinal metaplasia, Signet-ring cell carcinoma

Core tip: Gastric adenocarcinoma of fundic gland type is a very rare variant of a well-differentiated gastric adenocarcinoma. To the best of our knowledge, this is the first case report of gastric adenocarcinoma of fundic gland type with a signet-ring cell carcinoma component.



INTRODUCTION

Gastric adenocarcinoma showing chief cell differentiation was initially reported by Tsukamoto et al[1] in 2007. In 2010, Ueyama et al[2] reported 10 cases of gastric adenocarcinoma showing chief cell differentiation which expressed pepsinogen-I (a marker for chief cells) and proposed the concept of gastric adenocarcinoma of fundic gland type (GA-FG). Since then, the concept of GA-FG has been widely recognized, and reported cases and studies have been gradually accumulated.

Because GA-FG is thought to originate from the gastric mucosa of the fundic gland region without chronic gastritis or intestinal metaplasia, it has been generally considered that GA-FG develops without Helicobacter pylori (H. pylori) infection[3]. However, cases of GA-FG with current H. pylori infection or post-eradiation therapy were recently reported[4,5]. GA-FG generally presents as a well-differentiated adenocarcinoma with mild nuclear atypia and is generally considered to have a low potential for malignancy, although an extremely rare case of advanced GA-FG showing high-grade malignancy was reported[6]. To the best of our knowledge, no GA-FG case with a poorly differentiated adenocarcinoma or signet-ring cell carcinoma component has been reported.

We recently encountered a case of GA-FG with a signet-ring carcinoma component which developed in a patient with current H. pylori infection, and we report the case as follows.

CASE REPORT

A 76-year-old Japanese woman visited a nearby clinic complaining of a dull feeling in the stomach. Esophagogastroduodenoscopy (EGD) revealed a depressed lesion at a gastric angle of the greater curvature side. She was referred to our hospital for further examination. She had been found to have an H. pylori infection by a urease test four years ago, but no eradication was performed. The depressed lesion was confirmed by an EGD performed at Koga Hospital 21 (Figure 1A) and narrow band imaging (Figure 1B) showed a relatively demarcated lesion with an irregular microsurface pattern. A biopsy of the depressed lesion was performed. Histologically, the biopsy specimens consisted of several fragments of gastric mucosa with intestinal metaplasia. Among the glands with intestinal metaplasia, a small number of atypical cells showing a signet-ring-cell-like appearance were found (Figure 1C). As these atypical cells were positive for immunohistochemistry of pan-cytokeratin (AE1/AE3), a pathological diagnosis of signet-ring cell carcinoma was made (Figure 1D). Endoscopic submucosal dissection (ESD) was performed.

Figure 1
Figure 1 Image from esophagogastroduodenoscopy. A: Depressed lesion was found at gastric angle of the greater curvature side; B: The narrow band imaging of the EGD showed a relatively demarcated lesion with an irregular microsurface pattern; C: The biopsy specimen from the depressed lesion. Among the glands with intestinal metaplasia, a small number of signet-ring cell carcinoma cells were found (HE; × 200). D: Signet-ring cell carcinoma cells were positive for immunohistochemistry of pan-cytokeratin (× 200). EGD: Esophagogastroduodenoscopy.
Pathological findings

The ESD specimen showed a slightly depressed lesion measuring 28 mm × 14 mm. In that lesion, a deeper depressed lesion measuring 12 mm × 3 mm was found. Histologically, a well-differentiated tubular adenocarcinoma mimicking the fundic gland cells, mainly the chief cells, proliferated at the deep layer of the lamina propria mucosae (Figure 2A). The tumor cells had slightly enlarged nuclei and showed mild nuclear atypia. The structure and differentiation toward the surfaces of the fundic gland were significantly disturbed compared to normal fundic glands (Figure 2B). The tumor had invaded into the submucosal layer, and the maximum depth of invasion was 400 μm (Figure 2C). No lymphatic or venous invasion was observed. The mucosal surface was covered with non-neoplastic foveolar epithelium.

Figure 2
Figure 2 Pathological findings. A: Representative histological photograph of the specimens of endoscopic submucosal dissection (HE; × 50). Proliferation of gastric adenocarcinoma of the fundic gland type (GA-FG) are observed at the deep layer of the lamina propria mucosae in the left half of the photo (blue dot line: the border of GA-FG). Adjacent to the GA-FG, proliferation of the signet-ring cell carcinoma producing intra- and extracellular mucin is observed in the right half of the photo (yellow dotted line: border of the signet-ring cell carcinoma). Intestinal metaplasia was observed at the mucosa surrounding the signet-ring cell carcinoma (arrows); B: Structure and differentiation toward the surfaces of the fundic gland were significantly disturbed at the GA-FG compared to the normal fundic glands (HE; × 50). The blue line is the border of the GA-FG and the normal fundic glands. The mucosal surface was covered with non-neoplastic foveolar epithelium. Intestinal metaplasia cannot be observed in this photo; C: GA-FG invaded into the submucosal layer (HE; × 100).

Adjacent to the well-differentiated tubular adenocarcinoma mimicking fundic gland cells, proliferation of a signet-ring cell carcinoma producing intra- and extracellular mucin was observed (Figure 2A). Proliferation of the signet-ring cell carcinoma was restricted within the lamina propria mucosae, and no lymphatic or venous invasion was observed. Focally, intestinal metaplasia was observed at the mucosa surrounding the signet-ring cell carcinoma (Figure 2A).

In immunohistochemistry, the tumor cells of well-differentiated tubular adenocarcinoma expressed focally (30%) pepsinogen-I (Figure 3A), diffusely MUC6 (Figure 3B) and scattered (5%) H+/K+ ATPase (Figure 3C). Therefore, we diagnosed this tumor as GA-FG. The tumor cells of GA-FG were negative for MUC 2 but diffusely positive for MUC 5AC (Figure 3D). Meanwhile, the tumor cells of the signet-ring cell carcinoma were diffusely positive for MUC 2 (Figure 3E) and MUC 5AC (Figure 3F) but negative for pepsinogen-I, MUC6, and H+/K+ ATPase. The immunohistochemistry results are summarized in Table 1.

Table 1 Results of Immunohistochemistry.
MUC 6H+/K+ ATPasePepsinogen-IMUC5ACMUC2
Gastric adenocarcinoma of fundic gland type+ (Diffuse)+ (Scattered, 5%)+ (Focal, 30%)+ (Diffuse)-
Signet-ring cell carcinoma---+ (Diffuse)+ (Diffuse)
Figure 3
Figure 3 Photographs of immunohistochemistry. The magnifications of all photographs are × 200. The tumor cells of GA-FG expressed focally (30%) pepsinogen-I (A), diffusely MUC6 (B), scattered (5%) H+/K+ ATPase (C), and diffusely MUC5AC (D). The tumor cells of the signet-ring cell carcinoma diffusely expressed MUC 2 (E) and MUC 5AC (F). GA-FG: Gastric adenocarcinoma of fundic gland type.

Based on these HE and immunohistochemical findings, we made the final diagnosis of GA-FG with a signet-ring cell carcinoma component. The mapping based on histology revealed that GA-FG was distributed at a slightly depressed lesion (28 mm × 14 mm) and the signet-ring cell carcinoma was distributed at a deeper depressed lesion (12 mm × 3 mm) in the slightly depressed lesion (Figure 4).

Figure 4
Figure 4 Mapping of the endoscopic submucosal dissection specimen based on histology. GA-FG distributed at a slightly depressed lesion measuring 28 mm × 14 mm (red line) and signet-ring cell carcinoma distributed at a deeper depressed lesion measuring 12 mm × 3 mm in the slightly depressed lesion (yellow line). GA-FG: Gastric adenocarcinoma of fundic gland type.
DISCUSSION

GA-FG is a very rare variant of a well-differentiated gastric adenocarcinoma accounting for 1.6% of gastric adenocarcinomas[7]. GA-FGs are characterized by the following: (1) They arise most commonly from the normal gastric mucosa of the fundic gland region without intestinal metaplasia; (2) they are recognized as smooth elevated or depressed lesions; (3) they often invade the submucosal layer, while lymphatic and venous invasion are rare; and (4) the atypia of the tumor cell is usually mild[8]. The Wnt/β-catenin signal signaling pathway and GNAS mutations are considered to contribute to the development and progression of GA-FG[7,9,10].

Immunohistochemically, GA-FG variably express the following biomarkers of fundic gland cells: MUC6 for mucous neck cells; H+/K+ ATPase for parietal cells; and pepsinogen-I for chief cells. Typical cases diffusely express pepsinogen-I and MUC6 and show scattered positivity for H+/K+ ATPase. These cases are referred to as GA-FG of the chief cell predominant type[2]. GA-FGs do not express the intestinal-type mucin of MUC2.

The distinctive feature of present case was the coexistence of the signet-ring cell carcinoma and GA-FG. To the best of our knowledge, no GA-FG case which contains signet-ring cell carcinoma has been reported. The signet-ring cell carcinoma component in our case expressed the intestinal type of MUC2, and intestinal metaplasia was focally observed in the background mucosa. In addition, the present case had a current H. pylori infection. These are unusual findings for GA-FG.

The origin of the signet-ring cell carcinoma is a very interesting subject. We propose two hypotheses regarding this issue. First, these two lesions (GA-FG and the signet-ring cell carcinoma) may have accidentally coexisted. Usually, GA-FGs develop at the fundic gland in a deep layer of the gastric mucosa, and the normal foveolar epithelium remains at the surface. In the present case, intestinal metaplasia due to chronic inflammation caused by the H. pylori infection was focally observed at the surface of the mucosa. Therefore, it seems reasonable that the signet-ring cell carcinoma producing intestinal-type mucin developed at the surface of the mucosa from the intestinal metaplasia and that GA-FG simultaneously developed from the fundic gland of the deep layer of the mucosa. However, the probability for this situation to occur is considered extremely low.

The second hypothesis is that a part of the GA-FG dedifferentiated into signet-ring cell carcinoma. Although dedifferentiation or transformation is often observed in various types of malignant tumors, no GA-FG case showing dedifferentiation or transformation has been reported. Usually, GA-FGs do not express MUC5AC, which is a marker of the foveolar epithelium; however, it is known that GA-FGs rarely express MUC5AC[2,8,11]. In the present case, both the GA-FG and signet-ring cell carcinoma expressed MUC5AC. Ueyama et al[2] speculated that MUC5AC is only expressed in advanced GA-FG lesions with a large diameter and massive submucosal invasion, suggesting that cell differentiation changes from the fundic gland type to the foveolar type during disease progression. This speculation regarding MUC5AC seems to support the potential for the transformation of GA-FG. However, we believe it is impossible to conclusively determine the origin of the signet-ring cell carcinoma in the present case because of a lack of reliable evidence.

In conclusion, we have reported the first case of GA-FG with a signet-ring cell carcinoma component which expressed an intestinal type of mucin. Our case had a current H. pylori infection and showed focal intestinal metaplasia in the background mucosa. The origin of the signet-ring cell carcinoma is unclear at present. We expect the accumulation of the similar cases and further analysis of whether dedifferentiation or transformation can really occur in GA-FG.

ACKNOWLEDGMENTS

This case was presented and discussed at the 359th Kyushu-Okinawa slide conference. We thank the conference participants for their valuable comments and discussion. We are also grateful to the special commentators at that conference, Takashi Yao (Department of Human Pathology, Juntendo University School of Medicine) and Kazuya Akahoshi (Department of Gastroenterology, Aso Iizuka Hospital), for their valuable comments regarding the present case.

ARTICLE HIGHLIGHTS
Case characteristics

A 76-year-old Japanese woman visited a nearby clinic complaining of a dull feeling in the stomach.

Clinical diagnosis

Esophagogastroduodenoscopy (EGD) revealed a depressed lesion at a gastric angle of the greater curvature side.

Differential diagnosis

The clinical diagnosis of early gastric cancer was considered by EGD findings.

Laboratory diagnosis

No specific finding was obtained by laboratory testing.

Imaging diagnosis

The narrow band imaging of EGD showed a relatively demarcated lesion with an irregular microsurface pattern.

Pathological diagnosis

Pathological findings of endoscopic submucosal dissection (ESD) specimens indicated the diagnosis of gastric adenocarcinoma of fundic gland type (GA-FG) with a signet-ring cell carcinoma component.

Treatment

Only ESD was performed for treatment.

Related reports

To the best of our knowledge, no GA-FG case with a poorly differentiated adenocarcinoma or signet-ring cell carcinoma component has been reported.

Term explanation

The term GA-FG describes gastric adenocarcinoma of fundic gland type.

Experiences and lessons

This is the first case report of GA-FG with a signet-ring cell carcinoma component.

Footnotes

Manuscript source: Unsolicited manuscript

Specialty type: Gastroenterology and hepatology

Country of origin: Japan

Peer-review report classification

Grade A (Excellent): 0

Grade B (Very good): B

Grade C (Good): C

Grade D (Fair): 0

Grade E (Poor): 0

P- Reviewer: Abadi AT, Peixoto A S- Editor: Wang XJ L- Editor: A E- Editor: Yin SY

References
1.  Tsukamoto T, Yokoi T, Maruta S, Kitamura M, Yamamoto T, Ban H, Tatematsu M. Gastric adenocarcinoma with chief cell differentiation. Pathol Int. 2007;57:517-522.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 54]  [Cited by in F6Publishing: 55]  [Article Influence: 3.2]  [Reference Citation Analysis (1)]
2.  Ueyama H, Yao T, Nakashima Y, Hirakawa K, Oshiro Y, Hirahashi M, Iwashita A, Watanabe S. Gastric adenocarcinoma of fundic gland type (chief cell predominant type): proposal for a new entity of gastric adenocarcinoma. Am J Surg Pathol. 2010;34:609-619.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 120]  [Cited by in F6Publishing: 130]  [Article Influence: 9.3]  [Reference Citation Analysis (0)]
3.  Miyazawa M, Matsuda M, Yano M, Hara Y, Arihara F, Horita Y, Matsuda K, Sakai A, Noda Y. Gastric adenocarcinoma of the fundic gland (chief cell-predominant type): A review of endoscopic and clinicopathological features. World J Gastroenterol. 2016;22:10523-10531.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in CrossRef: 30]  [Cited by in F6Publishing: 28]  [Article Influence: 3.5]  [Reference Citation Analysis (0)]
4.  Chiba T, Kato K, Masuda T, Ohara S, Iwama N, Shimada T, Shibuya D. Clinicopathological features of gastric adenocarcinoma of the fundic gland (chief cell predominant type) by retrospective and prospective analyses of endoscopic findings. Dig Endosc. 2016;28:722-730.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 27]  [Cited by in F6Publishing: 28]  [Article Influence: 3.5]  [Reference Citation Analysis (0)]
5.  Manabe S, Mukaisho KI, Yasuoka T, Usui F, Matsuyama T, Hirata I, Boku Y, Takahashi S. Gastric adenocarcinoma of fundic gland type spreading to heterotopic gastric glands. World J Gastroenterol. 2017;23:7047-7053.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in CrossRef: 13]  [Cited by in F6Publishing: 13]  [Article Influence: 1.9]  [Reference Citation Analysis (0)]
6.  Ueo T, Yonemasu H, Ishida T. Gastric adenocarcinoma of fundic gland type with unusual behavior. Dig Endosc. 2014;26:293-294.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 27]  [Cited by in F6Publishing: 27]  [Article Influence: 2.7]  [Reference Citation Analysis (0)]
7.  Hidaka Y, Mitomi H, Saito T, Takahashi M, Lee SY, Matsumoto K, Yao T, Watanabe S. Alteration in the Wnt/β-catenin signaling pathway in gastric neoplasias of fundic gland (chief cell predominant) type. Hum Pathol. 2013;44:2438-2448.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 40]  [Cited by in F6Publishing: 41]  [Article Influence: 3.7]  [Reference Citation Analysis (0)]
8.  Miyazawa M, Matsuda M, Yano M, Hara Y, Arihara F, Horita Y, Matsuda K, Sakai A, Noda Y. Gastric adenocarcinoma of fundic gland type: Five cases treated with endoscopic resection. World J Gastroenterol. 2015;21:8208-8214.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in CrossRef: 27]  [Cited by in F6Publishing: 29]  [Article Influence: 3.2]  [Reference Citation Analysis (0)]
9.  Murakami T, Mitomi H, Yao T, Saito T, Shibuya T, Watanabe S. Epigenetic regulation of Wnt/β-catenin signal-associated genes in gastric neoplasia of the fundic gland (chief cell-predominant) type. Pathol Int. 2017;67:147-155.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 7]  [Cited by in F6Publishing: 7]  [Article Influence: 1.0]  [Reference Citation Analysis (0)]
10.  Kushima R, Sekine S, Matsubara A, Taniguchi H, Ikegami M, Tsuda H. Gastric adenocarcinoma of the fundic gland type shares common genetic and phenotypic features with pyloric gland adenoma. Pathol Int. 2013;63:318-325.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 40]  [Cited by in F6Publishing: 46]  [Article Influence: 5.1]  [Reference Citation Analysis (0)]
11.  Ueyama H, Matsumoto K, Nagahara A, Hayashi T, Yao T, Watanabe S. Gastric adenocarcinoma of the fundic gland type (chief cell predominant type). Endoscopy. 2014;46:153-157.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 23]  [Cited by in F6Publishing: 45]  [Article Influence: 4.5]  [Reference Citation Analysis (0)]